Market cap
$914m
Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
The Warrants will terminate when exercised in full. As of June 30, 2026, 3,000,000 Warrants were unexercised. Sales of Common Stock Pursuant to At-The-Market Facility In March 2026, the Company sold an aggregate of 18.4 million shares of its common stock for gross proceeds of $ 59.8 million, pursuant to an amended and restated sales agreement with Leerink Partners LLC and Cantor Fitzgerald & Co., as sales agents, dated February 27, 2025. …Aclaris Therapeutics, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06